Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
Clinical trial NCT04984733 · COMPLETED
Trial details
- NCT number
- NCT04984733
- Sponsor
- University of Southampton
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2024-10-23
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.